| Literature DB >> 33961825 |
Chengyue Zhu1, Kannan Maharajan1, Kechun Liu1, Yun Zhang2.
Abstract
Due to intense industrialization and urbanization, air pollution has become a serious global concern as a hazard to human health. Epidemiological studies found that exposure to atmospheric particulate matter (PM) causes severe health problems in human and significant damage to the physiological systems. In recent days, PM exposure could be related as a carrier for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus transmission and Coronavirus disease 2019 (COVID-19) infection. Hence, it is important to understand the adverse effects of PM in human health. This review aims to provide insights on the detrimental effects of PM in various human health problems including respiratory, circulatory, nervous, and immune system along with their possible toxicity mechanisms. Overall, this review highlights the potential relationship of PM with several life-limiting human diseases and their significance for better management strategies.Entities:
Keywords: Aerosols; Health effects; Molecular mechanism; Organ damage; Oxidative stress
Year: 2021 PMID: 33961825 PMCID: PMC8096764 DOI: 10.1016/j.envres.2021.111281
Source DB: PubMed Journal: Environ Res ISSN: 0013-9351 Impact factor: 6.498
Health effects of PM on the respiratory system.
| S. No. | PM type | Country/Location | Period | Patients/Subject | Health effects | Reference |
|---|---|---|---|---|---|---|
| 1. | PM10, PM2.5 and PM1 | Oporto, Portugal | 2018–2019 | 65 mothers and their newborns | PM10 deposited in the head region, while PM2.5 and PM1 deposited in the pulmonary area | |
| 2. | PM10, PM2.5 and PM1 | 7 Northeastern Chinese cities | 2012–2013 | 6740 children | Impaired lung function with significant impact on body mass index (BMI) | |
| 3. | PM10 and PM2.5 | 96 cities of China | 2013–2016 | Meteorological and hospital data | Increases the risk of COPD | |
| 4. | PM10 and PM2.5 | China | 2013–2018 | 69,491 patients | Increases the risk of respiratory system related diseases | |
| 5. | PM10 and PM2.5 | 4 Brazilian Southeast capitals | 2015–2018 | Meteorological and hospital data | Causes respiratory diseases | |
| 6. | PM10 | Taiwan | 2010–2012 | 120 children | Adverse effects on lung function | |
| 7. | PM10 | Bangkok, Thailand | 2013–2018 | Meteorological and hospital data | Respiratory diseases are associated with air pollution | |
| 8. | PM10 | England | 1991–1992 | 14,541 pregnant women with 13,963 children | Reductions in lung function in mid-childhood | |
| 9. | PM2.5 | Shanghai, China | 2012–2014 | 5281 participants | Decreases forced vital capacity (FVC), inspiration capacity (IC), and vital capacity (VC) with impaired lung function | |
| 10. | PM2.5 | Shenyang, China | 2015–2016 | 114 healthy volunteers | Causes imbalancein the oropharyngeal microbiota and impaired lung function in young people | |
| 11. | PM2.5 | United States | 2000–2018 | 7071 participants | Associated with increased emphysema | |
| 12. | PM | Eastern Massachusetts | 2012–2014 | 81 COPD patients | Promotes systemic oxidative stress |
Fig. 1Health effects of PM in respiratory system.
Health effects of PM on the cardiovascular system.
| S. No. | PM type | Country/Location | Period | Patients/Subject | Health effects | Reference |
|---|---|---|---|---|---|---|
| 1. | PM2.5, PM2.5–10 and PM10, | United States | 2007–2017 | 165,675 participants | PM2.5 is associated with higher leukocyte count and reduced CD8+ T-cell proportions. Increased risk for CVD | |
| 2. | PM2.5, PM2.5–10 and PM10 | Taiwan | 2006–2011 | 90 Patients with prior myocardial infarction | Affects cardiac autonomic balance | |
| 3. | PM10 and PM2.5 | Yichang, China | 2015–2017 | 391,960 inpatient admissions | Increases respiratory disease and CVD hospital admissions | |
| 4. | PM10 and PM2.5 | 9 cities in France, Iran and Italy | 2015–2016 | Meteorological and medical data | Increased risk of mortality for people with CVD and respiratory diseases | |
| 5. | PM2.5 | Ann Arbor, Michigan | Two weeks | 50 participants | Worsened aortic hemodynamics and increased the risk for CVD | |
| 6. | PM2.5 | Seoul, Korea | 2007 | 364 patients | Increased risk of rupture-prone coronary plaque | |
| 7. | PM2.5 | Allegheny County, Pennsylvania | 2007–2015 | 31,414 individuals with atrial Fibrillation (AF) | Associated with high risk of ischemic stroke | |
| 8. | PM2.5 | Shanghai, China | 2014–2016 | 1,016,579 participants outpatients | Increased risk of cardiac arrhythmias | |
| 9. | PM2.5 | United States | 2000 | 565,477 participants | Increased mortality due to ischemic heart disease and stroke | |
| 10 | PM2.5 | Swedish | 2018–2019 | 2927 participants | Increased dementia incidence via the heart failure and ischemic heart disease | |
| 11. | PM2.5 | China | 2016–2017 | 2337 patients in intensive cardiac care unit | High risk of acute non-cardiovascular critical illnesses | |
| 12. | PM2.5 | North Carolina | 2004–2016 | 35,084 heart failure patients | Increased risk in individuals with cardiac failure | |
| 13. | PM 2.5 | Boston | 2011–2012 | 237 maternal–infant pairs | Disrupt cardiac vagal tone during infancy, reduced autonomic flexibility | |
| 14. | PM2.5 | China | 2013–2016 | Meteorological and medical data | Increased risks of CVD death |
Fig. 2Health effects of PM in cardiovascular system.
Health effects of PM on the nervous system.
| S. No. | PM type | Country/Location | Period | Patients/Subject | Health effects | Reference |
|---|---|---|---|---|---|---|
| 1. | PM10 and PM2.5 | Mexico | 2016–2017 | 120 children | Diminished olfactory identification performance and affected CNS function | |
| 2. | PM10 and PM2.5 | 13 cities of China | 2013–2015 | 111,842 hospital outpatients | Increases mental disorders exacerbations | |
| 3. | PM10 and PM2.5 | China | 2014–2015 | 16,601 anxiety hospital admissions | Worsens the risks of anxiety hospitalizations | |
| 4. | PM10 | Saxony, Germany | 2005–2014 | 1,126,014 individuals | Increased risk of anxiety and depression | |
| 5. | PM2.5 | United Kingdom | 2006–2010 | 111,370 participants | Increases the risk of glaucoma via neurotoxic and/or vascular effects | |
| 6. | PM2.5 | Unites States | 1999–2010 | 998 participants | Increased risk for Alzheimer's disease | |
| 7. | PM2.5 | Boston, New York, Shanghai or Changsha | 2010–2014 | 135 first episode schizophrenia patients | Interacts with psychosis to reduce hippocampal volume | |
| 8. | PM2.5 | Denmark | 1989–2014 | 21,057 cases | Increased risk factor for CNS tumors | |
| 9. | PM2.5 | Mexico | 2007–2011 | 509 mothers | Increased the risk of Postpartum depression and neuropsychological dysfunction in mothers | |
| 10. | PM2.5 | Utah | 1986–2015 | 2444 pediatric patients and 13,459 young adult patients with cancer | Increases cancer mortality in pediatric lymphomas and CNS tumors | |
| 11. | PM2.5 | Barcelona | 2012–2014 | 186 participants | Decreased corpus callosum volume in pre-adolescent children and behavior problems | |
| 12. | PM | West Virginian counties, USA | 2001–2005 | Public Health and Socioeconomic Data | Increased dementia mortality |
Fig. 3Health effects of PM in nervous system.
Health effects of PM in the immune system.
| S. No. | PM type | Country/Location | Period | Patients/Subject | Health effects | Reference |
|---|---|---|---|---|---|---|
| 1. | PM10 and PM2.5 | Zhejiang and Shanxi, China | 2012–2014 | 120 participants | Increased mtDNA copy number and IL-5 concentration | |
| 2. | PM10 and PM2.5 | Italy | 2014–2015 | 50 healthy adult volunteers | Impaired the immune system | |
| 3. | PM10 and PM2.5 | Jinan, Shandong | 2016 | 163 and 110 school children from the polluted and control areas, respectively | Decreased C3 and C4 levels, and B lymphocyte count | |
| 4. | PM10 | South Korea | 2012–2013 | 100 participants | Impacts DNA methylation and immune responses | |
| 5. | PM2.5 | Mexico City | 2013–2017 | 35 residents | Alters functional immune cell responses and increased risk for Tuberculosis development | |
| 6. | PM2.5 | Japan | 2014–2015 | Cell line study | Activated antigen presenting cells and T-cells led to respiratory diseases | |
| 7. | PM2.5 | Shanghai, China | 2016 | 43 volunteers | Saliva lysozyme (non-specific immune biomarker) was significantly inversely associated with indoor PM2.5 | |
| 8. | PM2.5 | United States | 2012–2013 | 21 volunteers | Impairs critical antimycobacterial T cell immune functions | |
| 9. | PM2.5 | United States | 2003–2011 | 774 participants | Impacts DNA methylation and the human immune system | |
| 10 | PM2.5 | 252 Chinese cities | 2013–2017 | 117,338,867 hospital admissions | Increased risk of diseases in the digestive, musculoskeletal, and genitourinary systems |
Relationship between PM and COVID-19 infection.
| S. No. | PM type | Country/Location | Period | Observation | Reference |
|---|---|---|---|---|---|
| 1. | PM10 and PM2.5 | China | January 26th - February 29th, 2020 | PM2.5 has the potential of COVID-19 transmission | |
| 2. | PM10 and PM2.5 | China | January 23rd - February 29th, 2020 | Positively correlated with the risk of COVID-19 infection | |
| 3. | PM10 and PM2.5 | China | January 25th - February 29th, 2020 | PM2.5 increases the risk of COVID-19 infection | |
| 4. | PM10 and PM2.5 | China | Upto March 22nd, 2020 | Rise of every 10 | |
| 5 | PM10 and PM2.5 | United States | March 4th -April 24th, 2020 | Showed significant correlation between PM and COVID-19 | |
| 6. | PM10 and PM2.5 | France | March 18th - April 27th, 2020 | Direct association with COVID-19 mortality | |
| 7. | PM10 and PM2.5 | Middle Eastern Countries | n.a. | Indoor burning could enable the possible spread of SARS-CoV-2 virus droplets | |
| 8. | PM10 and PM2.5 | Italy | Upto March 31, 2020 | Chronic exposure to PM2.5 causes alveolar ACE-2 receptor overexpression that links to COVID-19 infection | |
| 9. | PM10 and PM2.5 | Italy | Upto April 27th, 2020 | Favors the transmission of SARS-CoV-2 infection | |
| 10. | PM10 | Italy | February 10th - February 29th, 2020 | Reported the presence of SARS-CoV-2 on PM | |
| 11. | PM10 | Italy | Upto April 7th, 2020 | Transmission of COVID-19 is mainly by the air pollution | |
| 12. | PM2.5 | United States | Upto April 22nd, 2020 | Increase of PM2.5 by 1 | |
| 13. | PM2.5 | New York | March 1st - April 20th, 2020 | PM2.5 was significantly associated COVID-19 infection, but not correlated with mortality |
Note: n.a. – data not available.
Fig. 4Impact of PM on COVID-19 and its possible health effects.
Regulation guidelines for particulate matters (PM10 and PM2.5) in different countries.
| S. No. | Country | Reference | ||||
|---|---|---|---|---|---|---|
| PM10 | PM2.5 | PM10 | PM2.5 | |||
| China | 150 | 75 | 70 | 35 | ||
| India | 100 | 60 | 60 | 40 | ||
| United States | 150 | 35 | n.a. | 12 | ||
| European Union | 50 | n.a. | 40 | 25 | ||
| Australia | 50 | 25 | 25 | 8 | ||
| Canada | n.a. | 27 | n.a. | 8.8 | ||
| Japan | n.a. | 35 | n.a. | 15 | ||
| WHO | 50 | 25 | 20 | 10 | ||
n.a. – data not available.